Reduced indinavir exposure during pregnancy

AIM: To describe the pharmacokinetics and safety of indinavir boosted with ritonavir (IDV/r) during the second and third trimesters of pregnancy and in the post-partum period. METHODS: IMPAACT P1026s is an on-going, prospective, non-blinded study of antiretroviral pharmacokinetics (PK) in HIV-infect...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cressey, Tim R, Best, Brookie M, Achalapong, Jullapong, Stek, Alice, Wang, Jiajia, Chotivanich, Nantasak, Yuthavisuthi, Prapap, Suriyachai, Pornnapa, Prommas, Sinart, Shapiro, David E, Watts, D Heather, Smith, Elizabeth, Capparelli, Edmund, Kreitchmann, Regis, Mirochnick, Mark
Formato: Artigo
Lenguaje:Inglês
Publicado: Blackwell Science Inc 2013
Materias:
Drugs in Pregnancy and Lactation
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3769674/
https://ncbi.nlm.nih.gov/pubmed/23305215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12078
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares